Evidence map›Paper›PMID 41084735›Full record

ArticleTherapeutic advances in chronic disease2025

Short- and long-term complications of insulin pump therapy in children and adolescents with type 1 diabetes: a multicenter cross-sectional study from Saudi Arabia.

Ayman Bakkar, Enad Althobaiti, Ibtisam Alqahtani, Lujain A Abualkhair, Naglaa M Kamal, Mohammed Althobaiti, Turki Alotaibi, Lura Habib, Lujain Alharthi, Saad Aljuaid and 7 more

Abstract read
In one paragraph

Article in Therapeutic advances in chronic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ayman BakkarPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.ORCID https://orcid.org/0000-0003-0266-8728
Enad AlthobaitiPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Ibtisam AlqahtaniPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Lujain A AbualkhairPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Naglaa M KamalPediatric Hepatology Unit, Faculty of Medicine, Cairo University, P.O. Box, Cairo 12613, Egypt.ORCID https://orcid.org/0000-0002-8535-3838
Mohammed AlthobaitiPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Turki AlotaibiPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Lura HabibPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Lujain AlharthiPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Saad AljuaidPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Maha AlthuwaybiPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Haneen AlshehriPediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Muhannad AlotaibiTaif University, Taif, Saudi Arabia.
Wael KamalPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Mutlaq AljuaidPrince Mansour Military Hospital, Taif, Saudi Arabia.
Samia AlmalkiPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.
Abdulaziz AlsaediPediatric Endocrine Division, Pediatric Department, Al Hada Armed Forces Hospital, Taif, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Insulin pump therapy improves glycemic control in children with type 1 diabetes but is associated with technical and dermatological complications that can impact adherence. Research on these adverse effects in pediatric populations is limited. Objectives: This study aimed to evaluate short- and long-term complications of insulin pump therapy in pediatric patients in Saudi Arabia, focusing on technical malfunctions, dermatological issues, and patient satisfaction. Design: A cross-sectional survey-based study conducted in multiple centers in Taif, Saudi Arabia. Methods: Fifty-nine parents of children with type 1 diabetes who used insulin pumps provided data for the study. Participants reported technical issues, skin-related complications, and overall satisfaction. IBM SPSS Statistics version 27.0.1 was used to conduct the statistical analysis. Results: Technical complications were frequent, with 64.4% experiencing tube blockages, 39.0% reporting needle dislodgment, and 39.0% observing air bubbles in the tubing. Dermatological issues included discomfort at the infusion site (54.2%), skin pigmentation (45.8%), and scarring (55.9%), with lipohypertrophy (22.0%) posing a concern for insulin absorption. Longer pump use was significantly associated with increased complications, particularly tube blockages and skin pigmentation. Despite these challenges, 84.7% of participants recommended insulin pumps over multiple daily injections. Conclusion: Technical and dermatological complications were common, increasing with longer pump use. Proper infusion site rotation, infusion set management, and improved patient education are key to reducing adverse effects. To improve safety and efficacy, future studies should concentrate on infusion set change patterns, newer pump technologies, and standardized guidelines.

Indexed as

continuous subcutaneous insulin infusion (CSII)device complicationsinsulin pumppediatricssafety issuestype 1 diabetes mellitus

Identifiers

PMID41084735
PMCPMC12515280

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.